C1826600||CKIP-1 P21A
C0752046||polymorphism
C0264716||chronic heart failure
C0152035||Chinese population
C1383860||cardiac hypertrophy
C0035648||risk factor
C0264716||chronic heart failure
C1309499||Casein kinase-2 interacting protein-1
C1309499||Casein kinase-2 interacting protein-1
C1383860||cardiac hypertrophy
C1826600||Casein kinase-2 interacting protein-1
C0752046||nonsynonymous polymorphism rs2306235
C0026882||Pro21Ala
C0033325||prognosis
C0264716||chronic heart failure
C0152035||Chinese population
C0264716||chronic heart failure
C1826600||CKIP-1 rs2306235
C0752046||polymorphism
C1285573||genotyped
C0032520||PCR
C3714764||restriction fragment length polymorphism
C1522577||follow-up
C0264716||chronic heart failure
C0220825||evaluated
C1826600||rs2306235
C0002085||G allele
C0264716||chronic heart failure
C0020538||hypertension
C0010068||coronary heart disease
C0035648||risk factors
C1826600||rs2306235
C0752046||polymorphism
C0264716||chronic heart failure
C1826600||CKIP-1 rs2306235
C0752046||polymorphism
C0035648||risk factor
C0264716||chronic heart failure